CD151-A Striking Marker for Cancer Therapy

• Published in: Biomarkers in Cancer Vol. 2015; no. 7; pp. 7 - 11
• Main Authors: Kumari, Seema, Gayatri Devi, V., Badana, Anil, Dasari, Venkata Ramesh, Malla, Rama Rao
• Format: Journal Article Book Review
• Language: English
• Published: London, England Libertas Academica 01.01.2015; SAGE Publishing; SAGE Publications; Sage Publications Ltd
• Subjects: Review; integrins; CD151; metastasis; tetraspanin
• ISSN: 1179-299X; 1179-299X
• DOI: 10.4137/BIC.S21847

Cluster of differentiation 151 (CD151) is a member of the mammalian tetraspanin family, which is involved in diverse functions such as maintaining normal cellular integrity, cell-to-cell communication, wound healing, platelet aggregation, trafficking, cell motility and angiogenesis. CD151 also supports de novo carcinogenesis in human skin squamous cell carcinoma (SCC) and tumor metastasis. CD151 interacts with α3β1 and α6β4 integrins through palmitoylation where cysteine plays an important role in the association of CD151 with integrins and non-integrin proteins. Invasion and metastasis of cancer cells were diminished by decreasing CD151 association with integrins. CD151 functions at various stages of cancer, including metastatic cascade and primary tumor growth, thus reinforcing the importance of CD151 as a target in oncology. The present review highlights the role of CD151 in tumor metastasis and its importance in cancer therapy.